All writers

Peter Sullivan

www.axios.com
8
articles (90 days)

Recent articles

Scoop: Bipartisan health package likely moving forward
Congressional negotiators are expected to release a bipartisan health care package as soon as today that revives major parts of a deal that was torpedoed in late 2024 by Elon Musk and then Presiden...
www.axios.com
Trump lays out new framework to address health costs
President Trump on Thursday called on Congress to pass a package of measures aimed at lowering drug prices, insurance premiums and increasing health cost transparency.Why it matters: The "Great Hea...
www.axios.com
House passes ACA subsidies extension in dramatic vote
Seventeen House Republicans joined the chamber's Democrats on Thursday in voting to revive enhanced Affordable Care Act subsidies for three years. Why it matters: The dramatic 230-196 vote marked a...
www.axios.com
States get first awards from rural health fund
The Trump administration on Monday announced the first awards to states from the $50 billion rural health fund in this summer's Republican megabill — including a big award for Alaska, whose lawmake...
www.axios.com
House passes GOP health bill without subsidies
House Republican leaders on Wednesday withstood a standoff with renegade members over expiring Affordable Care Act subsidies and passed a GOP health care bill with conservative priorities that woul...
www.axios.com
House Republicans unveil new health plan. Here's what's in it
House Republicans unveiled details of their health care plan Friday ahead of planned votes next week. Why it matters: The plan does not include an extension of enhanced Affordable Care Act subsidie...
www.axios.com
Senate rejects rival Obamacare bills. Here's what that means for ACA subsidies
The Senate voted down competing health care proposals on Thursday, likely guaranteeing that the enhanced Affordable Care Act tax credits will expire at the end of the year. Why it matters: The fail...
www.axios.com
FDA reaches "tipping point" after high-level departures
Another abrupt departure of a high-ranking Food and Drug Administration official is raising alarm about a brain drain that could mean new drugs take longer to reach the public.Why it matters: Biote...
www.axios.com